Literature DB >> 8260434

Factors relating to coagulation, fibrinolysis and hepatic damage after liver resection.

A Oguro1, H Taniguchi, T Daidoh, A Itoh, N Tsukuda, T Takahashi.   

Abstract

A survey of the blood of twenty-two patients who had undergone hepatic resection was performed. Serum levels of alpha-2 plasmin inhibitor-plasmin complex initially decreased from 1.58 +/- 0.31 microgram/ml on the preoperative day (PREOP), to 0.92 +/- 0.14 mu/ml on the first postoperative day (POD 1), and then increased to 3.13 +/- 0.92 micrograms/ml on the seventh postoperative day (POD 7) (mean +/- SE)). Thrombin-anti-thrombin III complex (14.2 +/- 4.3 ng/ml on PREOP and 26.0 +/- 4.1 ng/ml on POD 7 (mean +/- SE)) and D-dimer (335 +/- 96 ng/ml on PREOP and 1859 +/- 258 ng/ml on POD 7 (mean +/- SE)) increased in the early postoperative stage. The level of 6-keto-prostaglandin F1 alpha increased after the operations (from 13.2 +/- 1.8 pg/ml on PREOP to 37.8 +/- 12.8 pg/ml on POD 7 (mean +/- SE)). The level of thromboxane B-2 decreased at first, and then gradually increased and returned to its preoperative level on POD 7 (144.7 +/- 43.8 pg/ml on PREOP, 57.6 +/- 27.5 pg/ml on POD 1 and 152.5 +/- 58.4 pg/ml on POD 7 (mean +/- SE)). Superoxide dismutase activity increased at first, and then gradually decreased, postoperatively (2.8 +/- 0.5 NU/ml on PREOP, 4.8 +/- 0.8 NU/ml on POD 1 and 2.6 +/- 0.3 NU/ml on POD 7 (mean +/- SE)). That is, biodefensive reactions which protect patients against the shift to disseminated intravascular coagulation (DIC) were inferred with by the increase in antiplatelet aggregation, despite the activation of coagulation and fibrinolytic mechanisms after hepatic resection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260434      PMCID: PMC2423674          DOI: 10.1155/1993/91843

Source DB:  PubMed          Journal:  HPB Surg        ISSN: 0894-8569


  5 in total

1.  Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.

Authors:  Cheng-Chung Wu; Wai-Meng Ho; Shao-Bin Cheng; Dah-Cherng Yeh; Mei-Chin Wen; Tse-Jia Liu; Fang-Ku P'eng
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  A nationwide analysis of the use and outcomes of perioperative epidural analgesia in patients undergoing hepatic and pancreatic surgery.

Authors:  Neda Amini; Yuhree Kim; Omar Hyder; Gaya Spolverato; Christopher L Wu; Andrew J Page; Timothy M Pawlik
Journal:  Am J Surg       Date:  2015-06-02       Impact factor: 2.565

3.  Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.

Authors:  Brian I Carr; Siddhartha Kar; Meifang Wang; Ziqiu Wang
Journal:  Cell Biol Int       Date:  2007-03-19       Impact factor: 3.612

4.  The Opioid-Sparing Effect of Perioperative Dexmedetomidine Combined with Oxycodone Infusion during Open Hepatectomy: A Randomized Controlled Trial.

Authors:  Benhou Zhang; Guifang Wang; Xiaopeng Liu; Tian-Long Wang; Ping Chi
Journal:  Front Pharmacol       Date:  2018-01-04       Impact factor: 5.810

5.  Bleeding in Hepatic Surgery: Sorting through Methods to Prevent It.

Authors:  Fabrizio Romano; Mattia Garancini; Fabio Uggeri; Luca Degrate; Luca Nespoli; Luca Gianotti; Angelo Nespoli; Franco Uggeri
Journal:  HPB Surg       Date:  2012-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.